| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| L-瓜氨酸; L-Citruline | CFN90551 | 372-75-8 | C6H13N3O3 = 175.18 | 20mg | QQ客服：2159513211 |
| 巴比妥钠; Sodium barbital | CFN00448 | 144-02-5 | C8H11N2NaO3 = 206.17 | 5mg | QQ客服：2159513211 |
| 氯吡格雷杂质 A; Clopidogrel Related Compound A | CFN90546 | 144457-28-3 | C15H14ClNO2S = 307.8 | 5mg | QQ客服：2056216494 |
| 氯吡格雷杂质 B; Clopidogrel Related Compound B | CFN90547 | 144750-52-7 | C16H17ClNO2SCl = 358.3 | 5mg | QQ客服：1413575084 |
| 氯吡格雷杂质 C; Clopidogrel Related Compound C | CFN90548 | 120202-71-3 | C16H18ClNO6S2 = 419.9 | 5mg | QQ客服：2056216494 |
| RA VII; RA VII | CFN92604 | 86229-97-2 | C41H50N6O9 = 770.9 | 5mg | QQ客服：2056216494 |
| RA-V; RA-V | CFN92605 | 64725-24-2 | C40H48N6O9 = 756.9 | 5mg | QQ客服：1413575084 |
| RA-XI; RA-XI | CFN92606 | 143277-27-4 | C42H50N6O11 = 814.9 | 5mg | QQ客服：1413575084 |
| 大麻酰胺H; Cannabisin H | CFN94001 | 403647-08-5 | C28H31NO8 = 509.55 | 5mg | QQ客服：215959384 |
| Nb-Feruloyltryptamine; Nb-Feruloyltryptamine | CFN94005 | 53905-13-8 | C20H20N2O3 = 336.39 | 5mg | QQ客服：2056216494 |
| N-阿魏羟色胺; Moschamine | CFN94006 | 68573-23-9 | C20H20N2O4 = 352.39 | 5mg | QQ客服：2159513211 |
| 顺-N-阿魏羟色胺; cis-Moschamine | CFN94007 | 193224-24-7 | C20H20N2O4 = 352.39 | 5mg | QQ客服：3257982914 |
| 3-羟基-2-苯基-丙酰胺; 3-Hydroxy-2-phenyl-propanamide | CFN94011 | 56598-62-0 | C9H11NO2 = 165.19 | 5mg | QQ客服：215959384 |
| 10-羟基-6-铁屎米酮; 10-Hydroxycanthin-6-one | CFN94012 | 86293-41-6 | C14H8N2O2 = 236.23 | 5mg | QQ客服：215959384 |
| Beta-茄边碱; Beta-Solamarine | CFN90552 | 3671-38-3 | C45H73NO15 = 868.07 | 5mg | QQ客服：215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)